Women’s Wear Daily
04.20.2014

Financial

Beauty

Financial

Page 4 of 1326

Nu Skin Faces Troubles in China

Investors are waiting for more details on the size and scope of the issues.

Inter Parfums SA Maintains Growth Trajectory

The company said operating profitability reached “an exceptionally high level” in 2013.

Inter Parfums Slides to Loss in Q4

The company was dragged down by the termination of the Burberry fragrance license in the prior year.

Coty Inc., beauty, financial, growth, nail-care, michele scannavini, fragrance, skin0care

Michele Scannavini Talks Growth at Coty Inc.

The beauty company sees growth ahead, despite challenging market conditions in Europe and North America.

Douglas Sells Off Confectionery Retail Arm

Douglas Group, which holds Douglas Perfumeries, has made a sweet deal by selling its Hussel chain to Emeram Capital Partners.

Symrise Q4 Profits Rise 3%

The German fragrance and flavors supplier’s 2013 net income gained 9 percent.

revlon, colomer group, deal, earnings, results,  q4, fourth, quarter, fy, full, year, 2013, loss, china, The Colomer Group, Lorenzo Delpani

Revlon Slides Into Loss in Q4

The beauty firm reported its year-end results against a backdrop of changes, including the acquisition of The Colomer Group and the exit from China.

Newsletters
Newsletters

Sign upSign up for WWD and FN newsletters to receive daily headlines, breaking news alerts and weekly industry wrap-ups.

Publications

ArticleFinder

Beauty


Choose By

Clear

How it works

Close

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.


Or